Meetings of the Council on Graduate Medical Education, 103842-103843 [2024-30076]
Download as PDF
<![CDATA[
103842
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices
FDA’s Center for Drug Evaluation and
Research (CDER), Center for Biologics
Evaluation and Research, Office of the
Commissioner, and any other Centers
will use this mechanism to test
communications and social and
behavioral methods about regulated
drug products on a variety of subjects
related to consumer, patient, or
healthcare professional perceptions,
beliefs, attitudes, behaviors, and use of
drug and biological products and related
materials. These subjects include social
and behavioral research, decisionmaking processes, and communication
and behavioral change strategies.
Further, in addition to overseeing the
safety of drug products when used
according to approved drug labeling or
as directed by a healthcare provider,
CDER conducts studies on topics related
to the safe and effective use of drug
products, and emerging safety issues in
areas such as: (1) nonmedical use of
approved drug products; (2) use of
unapproved and falsified (i.e.,
counterfeit, fake) drug products; (3) use
of botanical substances (e.g., cannabis
derived products); (4) controlled
substance prescribing decisions; (5)
bystander response to drug overdoses;
and (6) potentially false or misleading
information about drug products.
Reliable data on these and related topics
are a critical first step to understanding
whether further studies or action is
needed to protect public health.
Because often data on these topics are
not collected as part of routine
healthcare delivery or via established
Federal surveys, FDA requires the
development and validation of novel
instruments (i.e., interview and focus
group guides, questionnaires) and
approaches to gathering data on
emerging safety issues the methods used
to create and validate these instruments
may include interviews, focus groups,
small group discussions, pilot and test/
re-test survey launches, and external
validation against benchmark surveys.
In conducting research in these areas,
FDA will need to employ the following
validation methodology: (1) research to
assess knowledge, perceptions, and
experiences related to topics in the
above-mentioned areas with specific
target populations; (2) techniques to
evaluate sampling and recruitment
methods; and (3) evaluations of the
validity and reliability of survey
questionnaires in target populations.
In accordance with 5 CFR 1320.8(d),
FDA published a 60-day notice for
public comment on the proposed
collection of information in the Federal
Register of April 23, 2024 (89 FR
30381). Although one comment was
received, it was not responsive to the
four collection of information topics
solicited and therefore will not be
discussed in this document.
Annually, FDA projects about 25
social and behavioral studies using the
variety of test methods listed in this
document. FDA is revising this burden
to account for the number of studies we
have received in the last 3 years and to
better reflect the scope of the
information collection.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity
Interviews and Surveys ........................................
1 There
Dated: December 11, 2024.
P. Ritu Nalubola,
Associate Commissioner for Policy.
1
126,770
COGME meetings will be held
on:
• April 10, 2025, 8 a.m.–5 p.m.
eastern time (ET) and April 11, 2025, 8
a.m.–2 p.m. ET.
• September 11, 2025, 8 a.m.–5 p.m.
ET and September 12, 2025, 8 a.m.–4
p.m. ET.
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
Notice.
VerDate Sep<11>2014
18:08 Dec 18, 2024
Jkt 265001
Meetings will be held inperson, by teleconference, and/or on a
video conference platform. In-person
meetings will be held at 5600 Fishers
Lane, Rockville, Maryland 20857. For
updates on how the meetings will be
held, instructions for joining meetings,
and any other updates, visit the COGME
website 30 business days before the date
of the meeting at https://www.hrsa.gov/
ADDRESSES:
Meetings of the Council on Graduate
Medical Education
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Council on
Graduate Medical Education (COGME or
Council) will hold public meetings for
the 2025 calendar year (CY).
Information about COGME, agendas,
and materials for these meetings can be
found on the COGME website at:
https://www.hrsa.gov/advisorycommittees/graduate-medical-edu.
SUMMARY:
DATES:
[FR Doc. 2024–30224 Filed 12–18–24; 8:45 am]
lotter on DSK11XQN23PROD with NOTICES1
126,770
Total annual
responses
Average burden per
response
0.25 (15 minutes) ..........
Total hours
31,693
are no capital costs or operating and maintenance costs associated with this collection of information.
Based on a review of the information
collection since our last request for
OMB approval, our burden estimate for
this information collection reflects an
overall increase of 17,300 responses
with a corresponding increase of 4,325
hours. We attribute this adjustment to
the need to validate information in
specific areas.
ACTION:
Number of
responses per
respondent
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
advisory-committees/graduate-medicaledu/meetings.
FOR FURTHER INFORMATION CONTACT:
Shane Rogers, Designated Federal
Officer, Division of Medicine and
Dentistry, Bureau of Health Workforce,
HRSA, 5600 Fishers Lane, Room 15N39,
Rockville, Maryland 20857; 301–443–
5260; or SRogers@hrsa.gov.
SUPPLEMENTARY INFORMATION: COGME
provides advice and recommendations
to the Secretary of HHS and Congress on
policy, program development, and other
matters of significance regarding the
issues listed in section 762(a)(1) of the
Public Health Service Act. Issues
addressed by the COGME include the
supply and distribution of the physician
workforce in the United States,
including any projected shortages or
excesses, issues related to foreign
medical school graduates, the nature
and financing of undergraduate and
graduate medical education,
appropriation levels for certain
programs under title VII of the Public
Health Service Act, and deficiencies in
databases concerning the supply and
distribution of the physician workforce
and postgraduate programs for training
E:\FR\FM\19DEN1.SGM
19DEN1
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices
physicians. COGME submits reports not
less than every 5 years to the Secretary
of HHS; the Senate Committee on
Health, Education, Labor, and Pensions;
and the House of Representatives
Committee on Energy and Commerce.
Additionally, COGME encourages
entities providing graduate medical
education to conduct activities to
voluntarily achieve the
recommendations of the Council related
to appropriate efforts to be carried out
by hospitals, schools of medicine,
schools of osteopathic medicine, and
accrediting bodies with respect to the
supply and distribution of physicians in
the United States; current and future
shortages or excesses of physicians in
medical and surgical specialties and
subspecialties; and issues relating to
foreign medical school graduates,
including efforts for changes in
undergraduate and graduate medical
education programs.
Since priorities dictate meeting times,
be advised that start times, end times,
and agenda items are subject to change.
For CY 2025 meetings, agenda items
may include, but are not limited to:
discussions on team-based care and the
Senate Finance Committee’s Medicare
Graduate Medical Education draft
policy document. Refer to the COGME
website listed above for all current and
updated information concerning the CY
2025 COGME meetings, including
agendas and meeting materials that will
be posted 30 calendar days before the
meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting. Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to COGME
should be sent to Shane Rogers using
the contact information above at least 5
business days before the meeting date.
Individuals who need special assistance
or another reasonable accommodation
should notify Shane Rogers using the
contact information listed above at least
10 business days before the meeting(s)
they wish to attend. Since all in-person
meetings will occur in a federal
government building at 5600 Fishers
Lane, Rockville, MD 20857, attendees
must go through a security check to
enter the building. Members of the
public must notify the Designated
Federal Officer of their intent to attend
the in-person meeting 10 business days
before the meeting. Non-U.S. citizen
attendees must notify the Designated
Federal Officer of their planned
attendance at least 20 business days
VerDate Sep<11>2014
18:08 Dec 18, 2024
Jkt 265001
prior to the meeting to facilitate their
entry into the building. All attendees are
required to present government-issued
identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–30076 Filed 12–18–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meetings of the National Advisory
Council on Nurse Education and
Practice
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the National
Advisory Council on Nurse Education
and Practice (NACNEP) will hold public
meetings for the 2025 calendar year
(CY). Information about NACNEP,
agendas, and materials for these
meetings can be found on the NACNEP
website at: https://www.hrsa.gov/
advisory-committees/nursing/meetings.
DATES: NACNEP meetings will be on (all
in Eastern Time):
• March 5, 2025, 10 a.m.–4 p.m. and
March 6, 2024, 10 a.m.–4 p.m.
• May 14, 2025, 10 a.m.–4 p.m.
• August 6, 2025, 10 a.m.–4 p.m. and
August 7, 2025, 10 a.m.–4 p.m.
• December 4, 2024, 8 a.m.–5 p.m.
and December 4, 2025, 8 a.m.–2 p.m.
ADDRESSES: Meetings may be held inperson, by teleconference, and/or video
conference. For updates on how the
meeting will be held, visit the NACNEP
website 30 business days before the date
of the meeting, where instructions for
joining meetings either in-person or
remotely will also be posted. In-person
NACNEP meetings will be held at 5600
Fishers Lane, Rockville, Maryland,
20857. For meeting information
updates, go to the NACNEP website
meeting page at https://www.hrsa.gov/
advisory-committees/nursing/meetings.
FOR FURTHER INFORMATION CONTACT:
Justin Bala-Hampton, Designated
Federal Officer, Bureau of Health
Workforce, HRSA, 5600 Fishers Lane,
Rockville, Maryland, 20857; 301–945–
9880; or JBala-Hampton@hrsa.gov.
SUPPLEMENTARY INFORMATION: NACNEP
provides advice and recommendations
to the Secretary of Health and Human
SUMMARY:
PO 00000
Frm 00080
Fmt 4703
Sfmt 9990
103843
Services on policy, program
development, and other matters of
significance concerning the activities
under Title VIII of the Public Health
Service Act, including the range of
issues relating to the nurse workforce,
education, and practice improvement.
NACNEP also prepares and submits an
annual report to the Secretary of Health
and Human Services and Congress
describing its activities, including
NACNEP’s findings and
recommendations concerning activities
under Title VIII, as required by the
Public Health Service Act.
Since priorities dictate meeting times,
be advised that start times, end times,
and agenda items are subject to change.
For CY 2025 meetings, agenda items
may include, but are not limited to, the
nursing workforce (e.g., nursing
shortage, distribution, supply, and
access) nursing practice improvement,
nursing education, nursing work
environment and support, and other
Title VIII program activities. Refer to the
NACNEP website listed above for all
current and updated information
concerning the CY 2025 NACNEP
meetings, including draft agendas and
meeting materials that will be posted 30
calendar days before the meeting.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
statements in advance of the scheduled
meeting(s). Oral comments will be
honored in the order they are requested
and may be limited as time allows.
Requests to submit a written statement
or make oral comments to NACNEP
should be sent to Justin Bala-Hampton
using the contact information above at
least 5 business days before the meeting
date(s).
Individuals who need special
assistance or another reasonable
accommodation should notify Justin
Bala-Hampton using the contact
information listed above at least 10
business days before the meeting(s) they
wish to attend. Since all in-person
meetings will occur in a federal
government building, attendees must go
through a security check to enter the
building. Non-U.S. citizen attendees
must notify HRSA of their planned
attendance at least 20 business days
prior to the meeting to facilitate their
entry into the building. All attendees are
required to present government-issued
identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–30070 Filed 12–18–24; 8:45 am]
BILLING CODE 4165–15–P
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 89, Number 244 (Thursday, December 19, 2024)]
[Notices]
[Pages 103842-103843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30076]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meetings of the Council on Graduate Medical Education
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Council on Graduate Medical Education (COGME
or Council) will hold public meetings for the 2025 calendar year (CY).
Information about COGME, agendas, and materials for these meetings can
be found on the COGME website at: https://www.hrsa.gov/advisory-committees/graduate-medical-edu.
DATES: COGME meetings will be held on:
April 10, 2025, 8 a.m.-5 p.m. eastern time (ET) and April
11, 2025, 8 a.m.-2 p.m. ET.
September 11, 2025, 8 a.m.-5 p.m. ET and September 12,
2025, 8 a.m.-4 p.m. ET.
ADDRESSES: Meetings will be held in-person, by teleconference, and/or
on a video conference platform. In-person meetings will be held at 5600
Fishers Lane, Rockville, Maryland 20857. For updates on how the
meetings will be held, instructions for joining meetings, and any other
updates, visit the COGME website 30 business days before the date of
the meeting at https://www.hrsa.gov/advisory-committees/graduate-medical-edu/meetings.
FOR FURTHER INFORMATION CONTACT: Shane Rogers, Designated Federal
Officer, Division of Medicine and Dentistry, Bureau of Health
Workforce, HRSA, 5600 Fishers Lane, Room 15N39, Rockville, Maryland
20857; 301-443-5260; or [email protected].
SUPPLEMENTARY INFORMATION: COGME provides advice and recommendations
to the Secretary of HHS and Congress on policy, program development,
and other matters of significance regarding the issues listed in
section 762(a)(1) of the Public Health Service Act. Issues addressed by
the COGME include the supply and distribution of the physician
workforce in the United States, including any projected shortages or
excesses, issues related to foreign medical school graduates, the
nature and financing of undergraduate and graduate medical education,
appropriation levels for certain programs under title VII of the Public
Health Service Act, and deficiencies in databases concerning the supply
and distribution of the physician workforce and postgraduate programs
for training
[[Page 103843]]
physicians. COGME submits reports not less than every 5 years to the
Secretary of HHS; the Senate Committee on Health, Education, Labor, and
Pensions; and the House of Representatives Committee on Energy and
Commerce. Additionally, COGME encourages entities providing graduate
medical education to conduct activities to voluntarily achieve the
recommendations of the Council related to appropriate efforts to be
carried out by hospitals, schools of medicine, schools of osteopathic
medicine, and accrediting bodies with respect to the supply and
distribution of physicians in the United States; current and future
shortages or excesses of physicians in medical and surgical specialties
and subspecialties; and issues relating to foreign medical school
graduates, including efforts for changes in undergraduate and graduate
medical education programs.
Since priorities dictate meeting times, be advised that start
times, end times, and agenda items are subject to change. For CY 2025
meetings, agenda items may include, but are not limited to: discussions
on team-based care and the Senate Finance Committee's Medicare Graduate
Medical Education draft policy document. Refer to the COGME website
listed above for all current and updated information concerning the CY
2025 COGME meetings, including agendas and meeting materials that will
be posted 30 calendar days before the meeting.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting. Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to COGME should be
sent to Shane Rogers using the contact information above at least 5
business days before the meeting date. Individuals who need special
assistance or another reasonable accommodation should notify Shane
Rogers using the contact information listed above at least 10 business
days before the meeting(s) they wish to attend. Since all in-person
meetings will occur in a federal government building at 5600 Fishers
Lane, Rockville, MD 20857, attendees must go through a security check
to enter the building. Members of the public must notify the Designated
Federal Officer of their intent to attend the in-person meeting 10
business days before the meeting. Non-U.S. citizen attendees must
notify the Designated Federal Officer of their planned attendance at
least 20 business days prior to the meeting to facilitate their entry
into the building. All attendees are required to present government-
issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-30076 Filed 12-18-24; 8:45 am]
BILLING CODE 4165-15-P
